This information was published on 2026-03-17T00:21:05 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2605229 (IR 361480) |
| (220) |
16 Oct 2025
|
| (511) (510) |
Class 5
Pharmaceutical products, namely: neuroleptic products. |
| (540) |
|
| (730) |
Essential Pharma Switzerland GmbH
|
Find out more about publications on the About page.